Trial Profile
Pharmacokinetics study of Peramivir in Epithelial Lining Fluid, an open-label study.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Jun 2019
Price :
$35
*
At a glance
- Drugs Peramivir (Primary)
- Indications Influenza A virus infections
- Focus Biomarker; Pharmacokinetics
- 21 Mar 2017 Status changed from active, no longer recruiting to completed.
- 12 Jun 2013 Status changed from not yet recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 17 Apr 2012 New trial record